Factsheet
As of 23 Apr 2025
TMAN
-
Consumer Products
/
Personal Products & Pharmaceuticals
CG Report :
-
SET ESG Ratings :
-
Business Type
Business operations: 1.Manufactures and/or distributes pharmaceutical and healthcare products under the company's brands 2.Manufactures and/or distributes pharmaceutical and healthcare products under the brands of third parties
300.00
4,400.04
5,637.38
654.81
8.61
11.00
19.30 /
9.90
9.76
2.49
Company Profile
69/1 Soi Bangkhunthian 14, Samaedum, Bangkhunthian Bangkok 10150
0-2415-1007
0-2416-1241
KASIKORN SECURITIES PUBLIC COMPANY LIMITED
22 Oct 2024
16.30 @Par Value
0.75
Baht
0.75
Baht
Old -
: New - @
-
Shareholders
As of -
3,055 (as of 17 Oct 2024)
25.02% (as of 17 Oct 2024)
0.14% (as of 23 Apr 2025)
49.00% (as of 23 Apr 2025)
-
-
0.28% (as of 23 Apr 2025)
Board of Directors / Management
5 Yr Price Performance (Adjusted Price)
Change
Price Performance (Adjusted Price)
Statistics
Accumulated: Turnover Ratio, Value Trade/Day
Rate of Return
Dividend
Latest News
Auditor (Effective Until 31 Dec 2025)
Ms. NADSASIN WATTANAPAISAL (KPMG PHOOMCHAI AUDIT LIMITED)MISS VILAIVAN PHOLPRASERT (KPMG PHOOMCHAI AUDIT LIMITED)Miss NAWARAT NITIKEATIPONG (KPMG PHOOMCHAI AUDIT LIMITED)MR. EKKASIT CHUTHAMSATID (KPMG PHOOMCHAI AUDIT LIMITED)
Unqualified opinion
31 Dec
Financial Statements Submission Information
Financial Data
Statement of Financial Position Unit: M.Baht
Statement of Comprehensive Income Unit: M.Baht
Statement of Cash Flow Unit: M.Baht
Ratios Annualized : ROE,
ROA
Growth Rate (%)
Cash Cycle Annualized
Capital Movement (Last 3 Year)
Information only PP, PO, XR and XD
Trading Sign (Latest)
- Calculated from adjusted price
- Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
- The information is quarterly updated within 7 business days after the new financial statement is submitted
- Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.